Dergiler / Turkish Journal of Medical Sciences / 2019 / Cilt: 49 - Sayı: 3

Modulation of PTEN by hexarelin attenuates coronary artery ligation-induced heart failure in rats

Sayfa
945–958
Yayın Tarihi
2022-11-04
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Left ventricular (LV) function, oxidative stress, apoptosis, molecular analyses, and cardiac structural and pathological changesin rats were assessed.Results: The treatment of HF rats with hexarelin significantly induced the upregulation of phosphatase and tensin homologue (PTEN)expression and inhibited the phosphorylation of protein kinase B (Akt) and mammalian target of rapamycin (mTOR) to significantlyimprove LV function, ameliorate myocardial remodeling, and reduce oxidative stress.Conclusion: These findings indicate that hexarelin attenuates CAL-induced HF in rats by ameliorating myocardial remodeling, LVdysfunction, and oxidative stress via the upmodulation of PTEN signaling and downregulation of the Akt/mTOR signaling pathway.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/aim: Hexarelin is a synthetic growth hormone-releasing peptide that exerts cardioprotective effects.
📊
Temel Bulgular & Veri:This study investigated the therapeutic role of hexarelin and themechanisms underlying its cardioprotective effects against coronary artery ligation (CAL)-induced HF in rats.Materials and methods: Rats with four weeks of permanent CAL, induced myocardial infarction, and HF were randomly separated intofour groups: the control group (Ctrl), sham group (Sham), hexarelin treatment group (HF + Hx), and heart failure group (HF).
💡
Sonuç & Katkı:Left ventricular (LV) function, oxidative stress, apoptosis, molecular analyses, and cardiac structural and pathological changesin rats were assessed.Results: The treatment of HF rats with hexarelin significantly induced the upregulation of phosphatase and tensin homologue (PTEN)expression and inhibited the phosphorylation of protein kinase B (Akt) and mammalian target of rapamycin (mTOR) to significantlyimprove LV function, ameliorate myocardial remodeling, and reduce oxidative stress.Conclusion: These findings indicate that hexarelin attenuates CAL-induced HF in rats by ameliorating myocardial remodeling, LVdysfunction, and oxidative stress via the upmodulation of PTEN signaling and downregulation of the Akt/mTOR signaling pathway.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Background/aim: Hexarelin is a synthetic growth hormone-releasing peptide that exerts cardioprotective effects. However, itscardioprotective effect against heart failure (HF) is yet to be explained. This study investigated the therapeutic role of hexarelin and themechanisms underlying its cardioprotective effects against coronary artery ligation (CAL)-induced HF in rats.Materials and methods: Rats with four weeks of permanent CAL, induced myocardial infarction, and HF were randomly separated intofour groups: the control group (Ctrl), sham group (Sham), hexarelin treatment group (HF + Hx), and heart failure group (HF). The ratswere treated with subcutaneous injection of hexarelin (100 µg/kg) in the treatment group or saline in the other groups twice a day for30 days. Left ventricular (LV) function, oxidative stress, apoptosis, molecular analyses, and cardiac structural and pathological changesin rats were assessed.Results: The treatment of HF rats with hexarelin significantly induced the upregulation of phosphatase and tensin homologue (PTEN)expression and inhibited the phosphorylation of protein kinase B (Akt) and mammalian target of rapamycin (mTOR) to significantlyimprove LV function, ameliorate myocardial remodeling, and reduce oxidative stress.Conclusion: These findings indicate that hexarelin attenuates CAL-induced HF in rats by ameliorating myocardial remodeling, LVdysfunction, and oxidative stress via the upmodulation of PTEN signaling and downregulation of the Akt/mTOR signaling pathway.

🔖

Bu Makaleye Atıf Yap

SAAHENE, R., LIU, D., CHEN, L., WANG, Y., TIAN, G., AGBO, E., ZHAO, J., LI, M. (2022). Modulation of PTEN by hexarelin attenuates coronary artery ligation-induced heart failure in rats. Turkish Journal of Medical Sciences, Cilt: 49 - Sayı: 3, 945–958. https://ajindex.com/articles/610109

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Xu X, Ding F, Pang J, Gao X, Xu RK, Hao W, Cao JM, Chen C. Chronic administration of hexarelin attenuates cardiac fibrosis in the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 2012; 303: H703-H711
  2. Yusuf S, Reddy S, Ôunpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001; 104: 2746-2753
  3. Boersma E, Mercado N, Poldermans D, Gardien M, Vos J, Simoons ML. Acute myocardial infarction. Lancet 2003; 361: 847-858
  4. Jugdutt BI. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation 2003; 108: 1395-1403
  5. Kumar D, Jugdutt B. Apoptosis and oxidants in the heart. J Lab Clin Med 2003; 142: 288-297
  6. Melo LG, Pachori AS, Kong D, Gnecchi M, Wang K, Pratt RE, Dzau VJ. Molecular and cell-based therapies for protection, rescue, and repair of ischemic myocardium: reasons for cautious optimism. Circulation 2004; 109: 2386-2393
  7. Singla DK, Lyons GE, Kamp TJ. Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling. Am J Physiol Heart Circ Physiol 2007; 293: H1308-H1314
  8. Glass C, Singla DK. MicroRNA-1 transfected embryonic stem cells enhance cardiac myocyte differentiation and inhibit apoptosis by modulating the PTEN/Akt pathway in the infarcted heart. Am J Physiol Heart Circ Physiol 2011; 301: H2038-H2049
  9. Mao Y, Tokudome T, Kishimoto I. The cardiovascular action of hexarelin. J Geriatr Cardiol 2014; 11: 253-258
  10. Huang J, Li Y, Zhang J, Liu Y, Lu Q. The growth hormone secretagogue hexarelin protects rat cardiomyocytes from in vivo ischemia/reperfusion injury through interleukin-1 signaling pathway. Int Heart J 2017; 58: 257-263
  11. Filigheddu N, Fubini A, Baldanzi G, Cutrupi S, Ghè C, Catapano F, Broglio F, Bosia A, Papotti M, Muccioli G et al. Hexarelin protects H9c2 cardiomyocytes from doxorubicin-induced cell death. Endocrine 2001; 14: 113-119
  12. Broglio F, Guarracino F, Benso A, Gottero C, Prodam F, Granata R, Avogadri E, Muccioli G, Deghenghi R, Ghigo E. Effects of acute hexarelin administration on cardiac performance in patients with coronary artery disease during by-pass surgery. Eur J Pharmacol 2002; 448: 193-200
  13. Sun Q, Ma Y, Zhang L, Zhao YF, Zang WJ, Chen C. Effects of GH secretagogues on contractility and Ca2+ homeostasis of isolated adult rat ventricular myocytes. Endocrinol